Today: 8 February 2026
Subscribe
Browse Category

NASDAQ:GP News 9 December 2025 - 15 January 2026

Pfizer stock dips as U.S. vaccine policy fight rattles demand outlook

Pfizer stock dips as U.S. vaccine policy fight rattles demand outlook

Pfizer shares fell 0.6% to $25.42 in late-morning trading Thursday as U.S. vaccine policy changes fueled uncertainty. Sanofi warned of weaker U.S. vaccine demand; Pfizer’s CEO criticized the new recommendations. Moderna and Merck also traded lower. Investors await Pfizer’s Feb. 3 results for updates on 2026 outlook and new product pipeline.
15 January 2026
········
Biggest Stock Gainers Today in the US (Dec. 9, 2025): Wave Life Sciences, Structure Therapeutics, Confluent and More

Biggest Stock Gainers Today in the US (Dec. 9, 2025): Wave Life Sciences, Structure Therapeutics, Confluent and More

Wave Life Sciences shares jumped about 147% Monday after positive data on its experimental RNA obesity drug, leading US stock gainers. The Dow fell 0.45%, S&P 500 lost 0.35%, and Nasdaq slipped 0.14% as investors awaited Wednesday’s Federal Reserve decision. Nvidia rose after the US allowed exports of its H200 AI chips to China with a 25% fee.
9 December 2025
····

Stock Market Today

LSEG share price heads into Monday after AI jitters hit London Stock Exchange Group stock

LSEG share price heads into Monday after AI jitters hit London Stock Exchange Group stock

8 February 2026
London Stock Exchange Group shares fell 1.1% to 7,502p Friday, closing out a third straight weekly decline and an 8% drop for the week. The selloff followed renewed concerns over AI disruption after a new Claude plug-in from Anthropic and caution over Big Tech’s AI spending. LSEG bought back 256,419 shares on Feb. 5. Investors await Monday’s open and LSEG’s FY25 results webcast on Feb. 26.
Anglo American share price slips after BofA downgrade as De Beers review looms

Anglo American share price slips after BofA downgrade as De Beers review looms

8 February 2026
Anglo American shares closed at 3,435 pence on Friday, down 0.75%, after BofA Global Research downgraded the miner to “neutral” over valuation and execution risks. The bank raised its price target to 3,600 pence but flagged a long wait for Teck synergies and uncertainty around De Beers. Investors await full-year results and updates on deals and disposals on Feb. 20.
GSK stock price: EU nod for Nucala in COPD puts the focus on Monday trade

GSK stock price: EU nod for Nucala in COPD puts the focus on Monday trade

8 February 2026
GSK shares closed Friday up 0.8% at 2,198 pence after the EU approved expanded use of Nucala for adults with uncontrolled COPD. Chairman Jonathan Symonds bought 2,500 shares earlier in the week. The stock is up 17% over the past week and nearly 49% in 12 months. GSK trades ex-dividend on Feb. 19.
BAT stock ends week higher as buyback rolls on; investors eye Feb 12 results

BAT stock ends week higher as buyback rolls on; investors eye Feb 12 results

8 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence on Friday, outpacing the FTSE 100 ahead of its preliminary results due Feb. 12. The company bought back 121,668 shares this week for cancellation. CEO Tadeu Marroco received 364 shares under a bonus scheme. Investors are watching for updates on BAT’s nicotine alternatives and sector competition after Philip Morris International’s latest results.
Go toTop